Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

bacteriophage, cell & molecular biology, disease & medicine
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Robert Fortner | Apr 12, 2020
Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.
Symptoms in ALS Mouse Model Improve with CRISPR Base Editing
Symptoms in ALS Mouse Model Improve with CRISPR Base Editing
Abby Olena | Apr 10, 2020
Researchers slowed disease progression in the mice by injecting two different viral vectors, each containing one part of the DNA encoding the Cas9 protein, to edit the causative gene.
Scientists Scan for Weaknesses in the SARS-CoV-2 Spike Protein
Scientists Scan for Weaknesses in the SARS-CoV-2 Spike Protein
Chris Baraniuk | Apr 9, 2020
The virus’s tool for prying open host cells is coated in a protective armor of sugar—but gaps may offer vulnerability to disruption by antibodies.
Journal Publisher Concerned over Hydroxychloroquine Study
Journal Publisher Concerned over Hydroxychloroquine Study
Kerry Grens | Apr 9, 2020
The report by Didier Raoult and colleagues that examined the use of the anti-malarial drug in a small number of COVID-19 patients receives criticism from the very society that published it.
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Ruth Williams | Apr 9, 2020
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
Image of the Day: Huo-Yan Air Lab
Image of the Day: Huo-Yan Air Lab
Amy Schleunes | Apr 9, 2020
An inflatable biosafety laboratory may help meet the global need for testing infrastructure during the COVID-19 pandemic.
Opinion: Ethically Accessing Experimental Therapies for COVID-19
Opinion: Ethically Accessing Experimental Therapies for COVID-19
John D. Loike and Jennifer E. Miller | Apr 8, 2020
In the midst of a pandemic, individual patients are not always the focus of the ethics discussions.
European Research Council President Resigns
European Research Council President Resigns
Amy Schleunes | Apr 8, 2020
Mauro Ferrari says the organization’s response to the COVID-19 pandemic is inadequate, but ERC members claim his proposals didn’t align with the mission of the council.
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Amy Schleunes | Apr 7, 2020
Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.
Study Questions if School Closures Limit the Spread of COVID-19
Study Questions if School Closures Limit the Spread of COVID-19
Ashley Yeager | Apr 7, 2020
School shutdowns might have a relatively small effect on preventing the transmission of SARS-CoV-2, a new meta-analysis suggests, though the preliminary data point to the need for more studies.